Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | ENO1 |
| Upstream (Parents) |
|---|
| (<<) ACTB → ENO1 |
| (<<) CYB5R3 → ENO1 |
| (<<) DAZAP2 → ENO1 |
| (<<) HSP90AB1 → ENO1 |
| (<<) HSPA8 → ENO1 |
| (<<) MCL1 → ENO1 |
| (<<) PPP1CA → ENO1 |
| (<<) RHOA → ENO1 |
| (<<) SHC1 → ENO1 |
| (<<) TAGLN2 → ENO1 |
| (<<) TPP1 → ENO1 |
| (<<) YWHAE → ENO1 |
| Downstream (Children) |
|---|
| ENO1 → ALDOA (>>) |
| ENO1 → ANXA2 (>>) |
| ENO1 → ATF4 (>>) |
| ENO1 → CDK8 (>>) |
| ENO1 → CFL1 (>>) |
| ENO1 → CIRH1A (>>) |
| ENO1 → COTL1 (>>) |
| ENO1 → CSTB (>>) |
| ENO1 → CYB561D1 (>>) |
| ENO1 → DHX9 (>>) |
| ENO1 → DUSP7 (>>) |
| ENO1 → DUSP9 (>>) |
| ENO1 → FOXB1 (>>) |
| ENO1 → GAPDH (>>) |
| ENO1 → GNB1 (>>) |
| ENO1 → GRIN2D (>>) |
| ENO1 → HES1 (>>) |
| ENO1 → ID1 (>>) |
| ENO1 → KLF6 (>>) |
| ENO1 → MAPK1 (>>) |
| ENO1 → MAPK12 (>>) |
| ENO1 → MT1F (>>) |
| ENO1 → MT1G (>>) |
| ENO1 → MTAP (>>) |
| ENO1 → NFATC3 (>>) |
| ENO1 → NMNAT1 (>>) |
| ENO1 → NOL9 (>>) |
| ENO1 → PGK1 (>>) |
| ENO1 → PKM2 (>>) |
| ENO1 → PLAUR (>>) |
| ENO1 → PPIF (>>) |
| ENO1 → RCAN1 (>>) |
| ENO1 → RPL35 (>>) |
| ENO1 → RPL36 (>>) |
| ENO1 → RPS16 (>>) |
| ENO1 → SEH1L (>>) |
| ENO1 → SMURF1 (>>) |
| ENO1 → SOD2 (>>) |
| ENO1 → STK4 (>>) |
| ENO1 → THOC4 (>>) |
| ENO1 → TK1 (>>) |
| ENO1 → TUBA1B (>>) |
| ENO1 → TUBB2C (>>) |
| ENO1 → VCP (>>) |
| ENO1 → VEGFA (>>) |
| ENO1 → ZSCAN10 (>>) |
